TOI
NASDAQ · Health Care
Oncology Institute Inc/The
$7.05
+0.22 (+3.22%)
Financial Highlights (FY 2026)
Revenue
395.88M
Net Income
-47,726,326
Gross Margin
15.2%
Profit Margin
-12.1%
Rev Growth
+25.8%
D/E Ratio
25.95
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 15.2% | 15.2% | 54.9% | 54.9% |
| Operating Margin | -7.2% | -6.5% | 16.6% | 15.3% |
| Profit Margin | -12.1% | -11.5% | 14.5% | 15.8% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 395.88M | 314.69M | 77.47M | 69.37M |
| Gross Profit | 60.17M | 47.83M | 42.55M | 38.11M |
| Operating Income | -28,424,266 | -20,335,325 | 12.86M | 10.62M |
| Net Income | -47,726,326 | -34,144,430 | 11.21M | 10.99M |
| Gross Margin | 15.2% | 15.2% | 54.9% | 54.9% |
| Operating Margin | -7.2% | -6.5% | 16.6% | 15.3% |
| Profit Margin | -12.1% | -11.5% | 14.5% | 15.8% |
| Rev Growth | +25.8% | +25.8% | +0.6% | -2.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 246.94M | 246.94M | 66.92M | 74.82M |
| Total Equity | 9.52M | 9.52M | 141.02M | 147.52M |
| D/E Ratio | 25.95 | 25.95 | 0.47 | 0.51 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -22,946,468 | -17,328,413 | 16.24M | 13.18M |
| Free Cash Flow | — | — | 11.97M | 11.86M |